Fluoropyrimidine-induced cardiac toxicity (video in Italian language)
Content: Luigi Tarantini (Cardiologist) – Footage and Adaptation: Rita Zilich
TOPICS COVERED IN THIS VIDEO TUTORIAL
-
The fluoropyrimidines
-
Epidemiology: there is great variability in the available data, but it seems that the incidence of heart damage is around 5%
-
Fluoropyrimidine cardiac damage pathogenesis
-
The cardiotoxic effects of fluoropyrimidines are characterized by vasoconstriction and, therefore, myocardial ischemia
-
Clinical manifestations
-
The most critical period of fluoropyrimidine cardiotoxicity
-
Who are the patients most at risk?
-
What to do in the presence of suspected cardiotoxicity
- Collaboration between oncologist and cardiologist is necessary
© All Rights Reserved